2010
DOI: 10.1002/cbic.201000072
|View full text |Cite
|
Sign up to set email alerts
|

RNA Grooves Can Accommodate Disulfide‐Bridged Bundles of α‐Helical Peptides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 15 publications
(20 citation statements)
references
References 53 publications
(36 reference statements)
0
20
0
Order By: Relevance
“…We have recently discovered that the penetrating concentration of a 16‐meric amphipathic α‐helical peptide (LKKLCKLLKKLCKLAG; leucine (L) and lysine (K)‐rich α‐helical (LK) peptide) could be greatly reduced by dimerization between two LK‐peptide molecules through the oxidative formation of two disulfide bonds 15. Remarkably, the dimeric peptide with an antiparallel structure as the major form can penetrate cells and inhibit the RNA transcription of HIV genes at nanomolar concentrations over 100‐fold lower than to the penetrating concentrations of other conventional CPPs such as Tat or oligoarginines.…”
Section: Resultsmentioning
confidence: 99%
“…We have recently discovered that the penetrating concentration of a 16‐meric amphipathic α‐helical peptide (LKKLCKLLKKLCKLAG; leucine (L) and lysine (K)‐rich α‐helical (LK) peptide) could be greatly reduced by dimerization between two LK‐peptide molecules through the oxidative formation of two disulfide bonds 15. Remarkably, the dimeric peptide with an antiparallel structure as the major form can penetrate cells and inhibit the RNA transcription of HIV genes at nanomolar concentrations over 100‐fold lower than to the penetrating concentrations of other conventional CPPs such as Tat or oligoarginines.…”
Section: Resultsmentioning
confidence: 99%
“…16b, 18 Another method is to perform a high-throughput screen using chemical libraries, in which a large number of diverse ligands can be screened against various RNAs with rapid turnover of results. 19 Several RNAs have been well-studied as therapeutic targets, including viral RNAs such as the HIV-1 dimerization initiation site (DIS) 20 and the HCV internal ribosome entry site (IRES), 21 as well as expanded nucleotide repeats r(CCUG) involved with the development of myotonic dystrophy type 2. 22 Herein, we focus on the review of medium-sized peptides and peptidomimetics used in targeting two conserved RNA structures of HIV-1: the transactivation response element (TAR) and rev response element (RRE) RNA, as well as the utilization of branched peptide scaffolds in therapeutics and our contribution in this field.…”
Section: Recognition Of Rna As a Therapeutic Targetmentioning
confidence: 99%
“…Through an alanine scan using 1 as a lead peptide, sequences 10 and 11 were found to improve binding affinities towards RRE, with each showing selectivity against TAR RNA. 21a Yu and co-workers also developed constrained peptides from 1 in which the 5 th and 12 th Leu residues were replaced with Cys and then cross-linked by various maleimido derivatives. 21b Unfortunately, none of the peptides showed increased binding affinity towards RRE in relation to 1 , with K d s ranging from 46 to 90 nM.…”
Section: Hiv-1 Rre Rna As a Therapeutic Targetmentioning
confidence: 99%
See 1 more Smart Citation
“…11 Several RNAs have been well-studied as therapeutic targets, including expanded nucleotide repeats r(CCUG) involved with the development of myotonic dystrophy type 2, 1215 as well as viral RNAs that contain targets such as the HIV-1 dimerization initiation site (DIS) 1619 and the HCV internal ribosome entry site (IRES). 20, 21 The Rev/Rev Response Element (RRE) pathway has become a high profile drug target due to its critical role in the proliferation of HIV-1. 22 RRE is a highly conserved region in the HIV-1 genome that spans approximately 351 nucleotides in the env gene.…”
Section: Introductionmentioning
confidence: 99%